552 related articles for article (PubMed ID: 32143622)
1. Specific chromatin landscapes and transcription factors couple breast cancer subtype with metastatic relapse to lung or brain.
Cai WL; Greer CB; Chen JF; Arnal-Estapé A; Cao J; Yan Q; Nguyen DX
BMC Med Genomics; 2020 Mar; 13(1):33. PubMed ID: 32143622
[TBL] [Abstract][Full Text] [Related]
2. Integrative analyses of scRNA-seq and scATAC-seq reveal CXCL14 as a key regulator of lymph node metastasis in breast cancer.
Xu K; Zhang W; Wang C; Hu L; Wang R; Wang C; Tang L; Zhou G; Zou B; Xie H; Tang J; Guan X
Hum Mol Genet; 2021 Apr; 30(5):370-380. PubMed ID: 33564857
[TBL] [Abstract][Full Text] [Related]
3. Cooperativity of co-factor NR2F2 with Pioneer Factors GATA3, FOXA1 in promoting ERα function.
Jiang G; Wang X; Sheng D; Zhou L; Liu Y; Xu C; Liu S; Zhang J
Theranostics; 2019; 9(22):6501-6516. PubMed ID: 31588232
[TBL] [Abstract][Full Text] [Related]
4. Integrated genomic and epigenomic analysis of breast cancer brain metastasis.
Salhia B; Kiefer J; Ross JT; Metapally R; Martinez RA; Johnson KN; DiPerna DM; Paquette KM; Jung S; Nasser S; Wallstrom G; Tembe W; Baker A; Carpten J; Resau J; Ryken T; Sibenaller Z; Petricoin EF; Liotta LA; Ramanathan RK; Berens ME; Tran NL
PLoS One; 2014; 9(1):e85448. PubMed ID: 24489661
[TBL] [Abstract][Full Text] [Related]
5. Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis.
Papageorgis P; Ozturk S; Lambert AW; Neophytou CM; Tzatsos A; Wong CK; Thiagalingam S; Constantinou AI
Breast Cancer Res; 2015 Jul; 17(1):98. PubMed ID: 26208975
[TBL] [Abstract][Full Text] [Related]
6. Differential open chromatin profile and transcriptomic signature define depot-specific human subcutaneous preadipocytes: primary outcomes.
Divoux A; Sandor K; Bojcsuk D; Talukder A; Li X; Balint BL; Osborne TF; Smith SR
Clin Epigenetics; 2018 Nov; 10(1):148. PubMed ID: 30477572
[TBL] [Abstract][Full Text] [Related]
7. Histone modification profiling in breast cancer cell lines highlights commonalities and differences among subtypes.
Xi Y; Shi J; Li W; Tanaka K; Allton KL; Richardson D; Li J; Franco HL; Nagari A; Malladi VS; Coletta LD; Simper MS; Keyomarsi K; Shen J; Bedford MT; Shi X; Barton MC; Kraus WL; Li W; Dent SYR
BMC Genomics; 2018 Feb; 19(1):150. PubMed ID: 29458327
[TBL] [Abstract][Full Text] [Related]
8. Simple oligonucleotide-based multiplexing of single-cell chromatin accessibility.
Wang K; Xiao Z; Yan Y; Ye R; Hu M; Bai S; Sei E; Qiao Y; Chen H; Lim B; Lin SH; Navin NE
Mol Cell; 2021 Oct; 81(20):4319-4332.e10. PubMed ID: 34686316
[TBL] [Abstract][Full Text] [Related]
9. Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast cancer.
Sirkisoon SR; Carpenter RL; Rimkus T; Anderson A; Harrison A; Lange AM; Jin G; Watabe K; Lo HW
Oncogene; 2018 May; 37(19):2502-2514. PubMed ID: 29449694
[TBL] [Abstract][Full Text] [Related]
10. Integrated analysis of ATAC-seq and RNA-seq reveals the transcriptional regulation network in SLE.
Wu J; Li Y; Feng D; Yu Y; Long H; Hu Z; Lu Q; Zhao M
Int Immunopharmacol; 2023 Mar; 116():109803. PubMed ID: 36738683
[TBL] [Abstract][Full Text] [Related]
11. Mapping Chromatin Accessibility in Human Naïve Pluripotent Stem Cells Using ATAC-Seq.
Cinkornpumin JK; Hossain I; Pastor WA
Methods Mol Biol; 2022; 2416():201-211. PubMed ID: 34870838
[TBL] [Abstract][Full Text] [Related]
12. ATAC-Seq Reveals an
Galang G; Mandla R; Ruan H; Jung C; Sinha T; Stone NR; Wu RS; Mannion BJ; Allu PKR; Chang K; Rammohan A; Shi MB; Pennacchio LA; Black BL; Vedantham V
Circ Res; 2020 Dec; 127(12):1502-1518. PubMed ID: 33044128
[TBL] [Abstract][Full Text] [Related]
13. Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse.
Harrell JC; Prat A; Parker JS; Fan C; He X; Carey L; Anders C; Ewend M; Perou CM
Breast Cancer Res Treat; 2012 Apr; 132(2):523-35. PubMed ID: 21671017
[TBL] [Abstract][Full Text] [Related]
14. XL-DNase-seq: improved footprinting of dynamic transcription factors.
Oh KS; Ha J; Baek S; Sung MH
Epigenetics Chromatin; 2019 Jun; 12(1):30. PubMed ID: 31164146
[TBL] [Abstract][Full Text] [Related]
15. SMARCE1 regulates metastatic potential of breast cancer cells through the HIF1A/PTK2 pathway.
Sethuraman A; Brown M; Seagroves TN; Wu ZH; Pfeffer LM; Fan M
Breast Cancer Res; 2016 Aug; 18(1):81. PubMed ID: 27495308
[TBL] [Abstract][Full Text] [Related]
16. Integrative epigenomic and high-throughput functional enhancer profiling reveals determinants of enhancer heterogeneity in gastric cancer.
Sheng T; Ho SWT; Ooi WF; Xu C; Xing M; Padmanabhan N; Huang KK; Ma L; Ray M; Guo YA; Sim NL; Anene-Nzelu CG; Chang MM; Razavi-Mohseni M; Beer MA; Foo RSY; Sundar R; Chan YH; Tan ALK; Ong X; Skanderup AJ; White KP; Jha S; Tan P
Genome Med; 2021 Oct; 13(1):158. PubMed ID: 34635154
[TBL] [Abstract][Full Text] [Related]
17. Dissecting the Epigenome Driving Drug Resistance by ATAC-Seq.
de Nicola F; Corleone G; Goeman F
Methods Mol Biol; 2022; 2535():171-185. PubMed ID: 35867231
[TBL] [Abstract][Full Text] [Related]
18. Systematic alteration of ATAC-seq for profiling open chromatin in cryopreserved nuclei preparations from livestock tissues.
Halstead MM; Kern C; Saelao P; Chanthavixay G; Wang Y; Delany ME; Zhou H; Ross PJ
Sci Rep; 2020 Mar; 10(1):5230. PubMed ID: 32251359
[TBL] [Abstract][Full Text] [Related]
19. ATAC-seq reveals alterations in open chromatin in pancreatic islets from subjects with type 2 diabetes.
Bysani M; Agren R; Davegårdh C; Volkov P; Rönn T; Unneberg P; Bacos K; Ling C
Sci Rep; 2019 May; 9(1):7785. PubMed ID: 31123324
[TBL] [Abstract][Full Text] [Related]
20. A BRCA1 deficient-like signature is enriched in breast cancer brain metastases and predicts DNA damage-induced poly (ADP-ribose) polymerase inhibitor sensitivity.
McMullin RP; Wittner BS; Yang C; Denton-Schneider BR; Hicks D; Singavarapu R; Moulis S; Lee J; Akbari MR; Narod SA; Aldape KD; Steeg PS; Ramaswamy S; Sgroi DC
Breast Cancer Res; 2014 Mar; 16(2):R25. PubMed ID: 24625110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
